SAO PAULO (Reuters) – Brazil health regulator Anvisa on Friday said it had approved use of the Pfizer/BioNtech COVID-19 vaccine for children over 12 years of age.
(Reporting by Eduardo Simoes; Editing by Alex Richardson)
SAO PAULO (Reuters) – Brazil health regulator Anvisa on Friday said it had approved use of the Pfizer/BioNtech COVID-19 vaccine for children over 12 years of age.
(Reporting by Eduardo Simoes; Editing by Alex Richardson)
